Macrophage Response to Particulates Plays a Pivotal Role in Development of Allergic Immune Response to Airborne Pollens
Takayasu Nomura, M.D., Takao Kobayashi, Ph.D., Koji Iijima, Ph.D., Kathleen R. Bartemes, PhD, and Hirohito Kita, MD; Mayo Clinic, Rochester, MN. RATIONALE: Innate immune responses in respiratory mucosa, such as those mediated by airway epithelial cells, likely play pivotal roles in development of type 2 immunity to inhaled allergens. The goal of this project was to investigate the roles for another innate immune cell type, namely airway macrophages, to induce allergic sensitization to pollens by using mouse models. METHODS: Na€ ıve BALB/c mice were exposed intranasally (i.n.) to ragweed pollen particles or ragweed extract twice a week for up to 3 weeks. Development of allergic immune responses was examined by analyzing sera and by challenging the animals i.n. with ragweed extract. The roles for macrophages were examined by in vitro culture and by depleting them in CD169-DTR transgenic mice. Clodronate liposome particles were used to characterize macrophage responses. RESULTS: Mice developed allergic immune responses to ragweed, including increased serum levels of IgE antibodies and airway eosinophilia, when exposed to ragweed pollen particles but not to ragweed extract. Pollen particles showed adjuvant activities to promote development of follicular helper T cells and allergen-specific IgE antibodies. Isolated airway macrophages produced IL-1a in response to pollen particles or clodronate liposome particles, but not to ragweed extract, in vitro. IL-1a and clodronate liposomes showed similar adjuvant activities as ragweed pollen particles to promote allergic immune responses in vivo. Finally, depletion of airway macrophages in CD169-DTR mice abolished IL-1a production and development of allergic immune response to ragweed pollens. CONCLUSIONS: Airway macrophages play a pivotal role to promote development of allergic immune responses to inhaled allergen particles. University CA -San Francisco, San Francisco, CA. RATIONALE: Growing evidence indicates that early life gut microbiome perturbation and associated metabolic dysfunction precede the development of childhood allergy and asthma. However, the extent of microbiota restructuring and its relationship to clinical and inflammatory features of established atopic asthma in adults remains largely unexplored. METHODS: Bacterial and fungal communities in stool samples collected from 36 atopic adults with mild asthma (AA), 20 atopic adults without asthma (ANA) and 19 non-atopic healthy controls (HC), were profiled by 16S rRNA and ITS biomarker sequencing, respectively. Statistical analyses were performed in Qiime and R environment. RESULTS: Bacterial gut microbiota in AAs was compositionally distinct from both ANAs and HC subjects (weighted UniFrac; PERMANOVA R 2 50.033, p50.050 and R 2 50.035, p50.045, respectively) and associated with predicted %FEV1 (R 2 50.037, p50.005). Variance in fungal gut microbiota composition was associated with bronchial hyperresponsiveness (Bray Curtis; PERMANOVA R 2 50.050, p50.011) and atopic status (R 2 50.074, p50.001). Allergic adults in this study (both AAs and ANAs) harbored less diverse (Shannon index; Welch's t-test p50.041) and less even (Welch's t-test p50.016) gut fungal communities compared to HC subjects. CONCLUSIONS: Imbalance in both fungal and bacterial gut microbiota is a signature of established atopic asthma, and features of these communities are associated with clinical markers of the disease.
Perturbations to fungal community composition in the adult gut appear to be associated with atopy, with or without coincident asthma.
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Hizikia fusiformis Ameliorates Allergic Inflammation in an Ova-induced Allergic Rhinitis Mouse Model.
Ji-Eun Lee; Medical College of Chosun University, Gwangju, Korea, Republic of (South). RATIONALE: Recently, several studies have reported that extract of Hizikia fusiformis (HF) shows the immune-modulatory, anti-cancer, antiatopic and anti-oxidant activities. The anti-inflammatory activity of HF suggests applications for diverse disorders including allergic and auto-immune, and sinonasal relative disease. We hypothesized that HF would alleviate the allergic rhinitis inflammation. METHODS: After establishment of allergic inflammation with OVA albumin in 4-week-old BALB/c mice, HF was administered intraperitoneally 5 times per week for one week during nasal challenging period in one group. The other group received addditional HF intraperitoneally 3 times during sensitization period. To compare its anti-inflammatory effects, triamcinolone acetonide (TAC) was utilized as a control drug. Histopathologic changes were evaluated using H&E stain for eosinophilic infiltration. The levels of IgG1, IgG2, Total IgE, ova-specific IgE was assessed. The levels of cytokines in the nasal mucosa were measured by Real-Time PCR. The levels of cytokines in spleen cell culture supernatant, including TNF, interleukin (IL)-4, IL-5, and IL-13, IL-10, IL-17 were assessed by ELISA. RESULTS: The allergic symptom score, ova-specific IgE, IgG2 level were lower in HF treated group compared to the TAC-treated or OVA (+) group, which was more obvious in the mice group received HF during sensitization and nasal challenge period. The cytokine IL-4,5,13 and IL-17 were significantly lower in the HF treated group compared with OVA (+) group.The degree of eosinophilic infiltration was significantly decreased by instillation of HF, the potency being greater than TAC. CONCLUSIONS: This study demonstrated that HF can suppress Th2 and Th17 responses in an AR murine model.
